Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. A8802 Compound
2. Iturelix
3. N-ac-nal(1)-4-cl-phe(2)-pal(3)-nic-lys(5)-nic-lys(6)-leu(7)-i-lys(8)-pro(9)-ala(10)-nh2
4. N-ac-nal(1)-4-cl-phe(2)-pal(3)-ser(4)-nic-lys(5)-nic-lys(6)-leu(7)-i-lys(8)-pro(9)-ala(10)-nh2
5. Nal-lys-gnrh
6. Nal-lys-gnrhant
7. Orf 23541
8. Orf-23541
1. Iturelix
2. 112568-12-4
3. Orf 23541
4. Nal-lys Anatagonist
5. Orf-32541
6. Antide Acetate
7. 94055uoq3y
8. Nal-lys-gnrhant
9. (n-acetyl-3-(naphhalen-2-yl)-d-alanyl)-p-chloro-d-phenylalanyl-3-(3-pyridyl)-d-alanyl-l-seryl-n(sup 6)-nicotinyl-l-lysyl-n(sup 6)-nicotinyl-d-lysyl-l-leucyl-n(sup 6)-isopropyl-l-lysyl-l-prolyl-d-alaninamide
10. Nal-lys-gnrh
11. D-alaninamide, N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n6-(3-pyridinylcarbonyl)-l-lysyl-n6-(3-pyridinylcarbonyl)-d-lysyl-l-leucyl-n6-(1-meth Ylethyl)-l-lysyl-l-prolyl-
12. Orf-23541
13. Iturelix [usan:inn]
14. Brn 4866881
15. Unii-94055uoq3y
16. Iturelix [usan]
17. Iturelix [inn]
18. Iturelix [who-dd]
19. D-alaninamide, N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n6-(3-pyridinylcarbonyl)-l-lysyl-n6-(3-pyridinylcarbonyl)-d-lysyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-
20. N-ac-nal(1)-4-cl-phe(2)-pal(3)-ser(4)-nic-lys(5)-nic-lys(6)-leu(7)-i-lys(8)-pro(9)-ala(10)-nh2
21. Gtpl3854
22. Schembl1649367
23. Chembl3989438
24. Dtxsid201033848
25. Akos015896023
26. D-alaninamide, N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n(sup 6)-(3-pyridinylcarbonyl)-l-lysyl-n(sup 6)-(3-pyridinylcarbonyl)-d-lysyl-l-leucyl-n(sup 6)-(1-methylethyl)-l-lysyl-l-prolyl-
27. D-alaninamide, N-acetyl-3-(naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n(sup 6)-3-pyridinylcarbonyl)-l-lysyl-n(sup 6)-(3-pyridinylcarbonyl)-d-lysyl-l-leucyl-n(sup 6)-(1-methylethyl)-l-lysyl-l-prolyl-
28. 568a124
29. D 21074
30. Q27888363
31. N-acetyl-3-(2-naphthyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridyl)-d-alanyl-l-seryl-n6-nicotinoyl-l-lysyl-n6-nicotinoyl-d-lysyl-l-leucyl-n6-isopropyl-l-lysyl-l-prolyl-d-alaninamide
Molecular Weight | 1591.3 g/mol |
---|---|
Molecular Formula | C82H108ClN17O14 |
XLogP3 | 5 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 46 |
Exact Mass | 1589.7950189 g/mol |
Monoisotopic Mass | 1589.7950189 g/mol |
Topological Polar Surface Area | 454 Ų |
Heavy Atom Count | 114 |
Formal Charge | 0 |
Complexity | 3110 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Hormone Antagonists
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
55
PharmaCompass offers a list of Antide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Antide manufacturer or Antide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Antide manufacturer or Antide supplier.
PharmaCompass also assists you with knowing the Antide API Price utilized in the formulation of products. Antide API Price is not always fixed or binding as the Antide Price is obtained through a variety of data sources. The Antide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Antide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antide, including repackagers and relabelers. The FDA regulates Antide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antide supplier is an individual or a company that provides Antide active pharmaceutical ingredient (API) or Antide finished formulations upon request. The Antide suppliers may include Antide API manufacturers, exporters, distributors and traders.
click here to find a list of Antide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Antide DMF (Drug Master File) is a document detailing the whole manufacturing process of Antide active pharmaceutical ingredient (API) in detail. Different forms of Antide DMFs exist exist since differing nations have different regulations, such as Antide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Antide DMF submitted to regulatory agencies in the US is known as a USDMF. Antide USDMF includes data on Antide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Antide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Antide suppliers with USDMF on PharmaCompass.
Antide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Antide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Antide GMP manufacturer or Antide GMP API supplier for your needs.
A Antide CoA (Certificate of Analysis) is a formal document that attests to Antide's compliance with Antide specifications and serves as a tool for batch-level quality control.
Antide CoA mostly includes findings from lab analyses of a specific batch. For each Antide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Antide may be tested according to a variety of international standards, such as European Pharmacopoeia (Antide EP), Antide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Antide USP).